-
公开(公告)号:US07592312B2
公开(公告)日:2009-09-22
申请号:US11548805
申请日:2006-10-12
IPC分类号: A61K38/00
CPC分类号: G01N33/6893 , A61K38/1709 , C07K14/47 , C07K14/4702 , G01N2800/06 , G01N2800/065
摘要: The present invention provides methods of using Zven1 and Zven2 polypeptides to increase chemokine production. The present invention also provides methods for treating intestinal motility disorders and improving gastrointestinal function with Zven1 and Zven2 polypeptides.
摘要翻译: 本发明提供使用Zven1和Zven2多肽来增加趋化因子产生的方法。 本发明还提供了用Zven1和Zven2多肽治疗肠蠕动障碍和改善胃肠功能的方法。
-
公开(公告)号:US07291589B2
公开(公告)日:2007-11-06
申请号:US10680800
申请日:2003-10-07
IPC分类号: A61K38/00
CPC分类号: G01N33/6893 , A61K38/1709 , C07K14/47 , C07K14/4702 , G01N2800/06 , G01N2800/065
摘要: The present invention provides methods of using Zven1 and Zven2 polypeptides to increase chemokine production. The present invention also provides methods for treating intestinal motility disorders and improving gastrointestinal function with Zven1 and Zven2 polypeptides.
-
公开(公告)号:US09629798B2
公开(公告)日:2017-04-25
申请号:US12935114
申请日:2009-03-26
申请人: Richard I. Senderoff , Jeffrey D. Meyer , Emily N. Rollins , Steven D. Hughes , Richard M. Garcia , Paul D. Bishop , Gerald W. Lasser
发明人: Richard I. Senderoff , Jeffrey D. Meyer , Emily N. Rollins , Steven D. Hughes , Richard M. Garcia , Paul D. Bishop , Gerald W. Lasser
CPC分类号: A61K47/42 , A61K9/0024 , A61K9/06 , A61K38/4833 , A61K47/10 , A61K47/26 , A61K47/32 , A61K47/38 , C12Y304/21005 , Y10T428/2982
摘要: Provided herein are hemostatic compositions. In one embodiment, the hemostatic composition includes cross-linked polymer microspheres, such as cross-linked gelatin microspheres with pores. In another embodiment, the hemostatic composition comprises an additive such as a wetting agent, a suspending agent, or both. The hemostatic compositions may also include a hemostatic agent such as thrombin, and may include a high concentration of thrombin. The hemostatic compositions may also include plasma. Also provided herein are devices for dispersing said hemostatic compositions in a diluent, and delivering said dispersed hemostatic composition. The hemostatic compositions may also fabricated with a selected geometry as administration suggests.
-
-